Patent details
EP2205595 Title: OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS
Basic Information
- Publication number:
- EP2205595
- PCT Application Number:
- PCT/EP/2008/062900
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088047790
- PCT Publication Number:
- WO/2009/040410
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS
- French Title of Invention:
- DÉRIVÉS DE BENZIMIDAZOLE ET D'INDOLE SUBSTITUÉS PAR DE L'OXADIAZOLE ET OXAZOLE COMME INHIBITEURS DE DGAT1
- German Title of Invention:
- OXADIAZOL- UND OXAZOL-SUBSTITUIERTE BENZIMIDAZOL- UND INDOL-DERIVATE ALS DGAT1-HEMMER
- SPC Number:
Dates
- Filing date:
- 26/09/2008
- Grant date:
- 10/09/2014
- EP Publication Date:
- 10/09/2014
- PCT Publication Date:
- 02/04/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/07/2010
- EP B1 Publication Date:
- 10/09/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/09/2014
- Expiration date:
- 26/09/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/09/2008
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- KWAK Young-Shin
- Address:
- United States (US)
2
- Name:
- COPPOLA Gary Mark
- Address:
- United States (US)
Priority
- Priority Number:
- 976064 P
- Priority Date:
- 28/09/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 413/04;
| Filing date | Document type | Number of pages |
|---|